{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=NR&page=4", "query": { "intervention": "NR", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 75, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=NR&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=NR&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T01:41:33.721Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03176628", "title": "Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Kidney Injury" ], "interventions": [ { "name": "Basis", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2017-11-01", "completion_date": "2018-09-11", "has_results": false, "last_update_posted_date": "2019-06-27", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03176628" }, { "nct_id": "NCT02509026", "title": "Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Spondylitis, Ankylosing" ], "interventions": [ { "name": "Etanercept", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 210, "start_date": "2015-09-24", "completion_date": "2019-09-06", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 12, "location_summary": "Pensacola, Florida • Chicago, Illinois • Mineola, New York + 4 more", "locations": [ { "city": "Pensacola", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Mineola", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02509026" }, { "nct_id": "NCT04342975", "title": "Protection From Acute Kidney Injury (AKI) With Basis™ Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "AKI" ], "interventions": [ { "name": "Nicotinamide Riboside + Pterostilbene", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2020-12-01", "completion_date": "2024-03-14", "has_results": false, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04342975" }, { "nct_id": "NCT03719105", "title": "Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "NK-Cell Lymphoma", "NK-Cell Leukemia", "Peripheral T Cell Lymphoma" ], "interventions": [ { "name": "Methotrexate", "type": "DRUG" }, { "name": "pralatraxate,", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "calaspargase pegol", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Brentuximab Vedotin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York Medical College", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "31 Years", "sex": "ALL", "summary": "1 Year to 31 Years" }, "enrollment_count": 40, "start_date": "2019-03-01", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 6, "location_summary": "Birmingham, Alabama • Orange, California • San Francisco, California + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Valhalla", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03719105" }, { "nct_id": "NCT05619419", "title": "Study of Affect Induction for Lab Induced Pain in Healthy Undergraduates", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meditation", "Pain", "Mindfulness", "Affect", "Emotion Regulation" ], "interventions": [ { "name": "Mindfulness-enhanced positive affect induction", "type": "BEHAVIORAL" }, { "name": "Breathing Meditation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 180, "start_date": "2022-03-14", "completion_date": "2022-11-14", "has_results": false, "last_update_posted_date": "2023-03-22", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05619419" }, { "nct_id": "NCT06030297", "title": "Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Peripheral Neuropathy" ], "interventions": [ { "name": "Diode Laser fiber type Selective Stimulator", "type": "PROCEDURE" }, { "name": "ZTlido 1.8 % Topical System", "type": "DRUG" }, { "name": "PeriCam PSI NR", "type": "DIAGNOSTIC_TEST" }, { "name": "Medoc Quantitative Sensory Testing", "type": "DIAGNOSTIC_TEST" }, { "name": "Inactive Topical System", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2023-09-01", "completion_date": "2026-02-09", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 2, "location_summary": "Palo Alto, California • Salt Lake City, Utah", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06030297" }, { "nct_id": "NCT04691986", "title": "Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sarcopenia", "Nicotinamide Adenine Dinucleotide Concentration", "Muscle Quality and NAD+ Content" ], "interventions": [ { "name": "Nicotinamide Riboside", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "65 Years to 85 Years" }, "enrollment_count": 74, "start_date": "2023-09-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04691986" }, { "nct_id": "NCT05194397", "title": "Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoblastic Leukemia", "Cancer Survivors", "Aplastic Anemia", "Myelodysplastic Syndromes", "Myeloid Leukemia" ], "interventions": [ { "name": "Nicotinamide Riboside", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" }, { "name": "Exercise Intervention", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "10 Years to 30 Years" }, "enrollment_count": 80, "start_date": "2023-02-23", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 3, "location_summary": "Duarte, California • Philadelphia, Pennsylvania • Memphis, Tennessee", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05194397" }, { "nct_id": "NCT01008150", "title": "Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Neratinib", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NSABP Foundation Inc", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 141, "start_date": "2010-10", "completion_date": "2016-11-25", "has_results": true, "last_update_posted_date": "2021-10-25", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 30, "location_summary": "Loma Linda, California • San Diego, California • Denver, Colorado + 25 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01008150" }, { "nct_id": "NCT03727646", "title": "Nicotinamide Riboside in LVAD Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Heart Failure，Congestive", "Heart Failure New York Heart Association Class IV", "Mitochondrial Alteration" ], "interventions": [ { "name": "Nicotinamide riboside", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 5, "start_date": "2018-09-26", "completion_date": "2018-11-26", "has_results": true, "last_update_posted_date": "2024-09-20", "last_synced_at": "2026-10-21T01:41:33.721Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03727646" } ] }